Collegium Pharmaceutical
COLL
21.93
+0.05
+0.23%
Collegium Pharmaceutical
US · COLL
#3535 by market cap
Listed 2015
21.93
+0.05
+0.23%
Live - 5344 symbols - heartbeat 25s ago
· 2026-10-08 08:33
Pre-market
22.01
+0.36%
After-hours
21.93
0.00%
- Market cap
- 679.81M
- P/E (TTM)i
- 17.27
- P/Bi
- 2.18
- EPSi
- 1.73
- Div yieldi
- 0.00%
- 52W posi
- 2%
Reader sentiment
Are you bullish or bearish on COLL?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
48.71 +122.1%
Price target rangecurrent 21.93
Low43.00
Avg48.71
High60.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | Oppenheimer | -- | BUY | 50.00 |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-09-09 | Truist Financial | -- | BUY | 49.00 |
| 2026-09-09 | Leerink Partners | -- | BUY | 45.00 |
| 2026-08-18 | Barclays | -- | BUY | 48.00 |
| 2026-08-07 | Piper Sandler | -- | HOLD | 43.00 |
| 2026-08-07 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-08-06 | Needham | -- | BUY | 46.00 |
| 2026-07-01 | Barclays | -- | BUY | 56.00 |
| 2026-05-14 | Truist Financial | -- | BUY | -- |
| 2026-05-12 | Needham | -- | BUY | 56.00 |
| 2026-05-12 | Barclays | -- | BUY | 56.00 |
| 2026-05-08 | Truist Financial | -- | BUY | -- |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-05-07 | Needham | -- | BUY | 56.00 |
| 2026-04-23 | Piper Sandler | -- | HOLD | 44.00 |
| 2026-04-23 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-04-20 | Piper Sandler | -- | HOLD | 44.00 |
| 2026-04-16 | Needham | -- | BUY | 56.00 |
| 2026-03-24 | Barclays | -- | BUY | 56.00 |
| 2026-03-20 | Piper Sandler | -- | HOLD | 44.00 |
| 2026-03-20 | Truist Financial | -- | BUY | 58.00 |
| 2026-03-20 | H.C. Wainwright | -- | BUY | 60.00 |
| 2026-03-19 | Needham | -- | BUY | 56.00 |
| 2026-03-19 | Barclays | -- | BUY | 56.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±10.36% | -18.55% (beat) |
| 2026/Q1 | 2026-05-07 | -- | ±18.26% | +7.72% (in line) |
| 2025/Q4 | 2026-02-26 | -- | ±8.80% | -3.34% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±13.21% | +13.42% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±13.38% | +10.72% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±10.56% | +5.94% (in line) |
| 2024/Q4 | 2025-02-27 | After close | ±16.79% | +2.22% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±9.68% | -7.35% (in line) |
| 2024/Q2 | 2024-08-08 | After close | ±8.73% | +0.51% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±16.30% | -16.80% (beat) |
| 2023/Q4 | 2024-02-22 | After close | ±13.56% | +10.79% (in line) |
| 2023/Q3 | 2023-11-07 | After close | ±16.86% | +6.60% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:33:16 · For reference only, not investment advice and not tailored to your situation.